{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T14:34:17Z","timestamp":1791815657477,"version":"4.3.4"},"reference-count":35,"publisher":"American Medical Association (AMA)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Neurol"],"published-print":{"date-parts":[[2020,3,1]]},"DOI":"10.1001\/jamaneurol.2019.4347","type":"journal-article","created":{"date-parts":[[2019,12,20]],"date-time":"2019-12-20T16:38:50Z","timestamp":1576859930000},"page":"377","source":"Crossref","is-referenced-by-count":172,"title":["Diagnosis Across the Spectrum of Progressive Supranuclear Palsy and Corticobasal Syndrome"],"prefix":"10.1001","volume":"77","author":[{"given":"Edwin","family":"Jabbari","sequence":"first","affiliation":[{"name":"Department of Clinical and Movement Neurosciences, UCL (University College London) Queen Square Institute of Neurology, London, United Kingdom"},{"name":"Movement Disorders Centre, UCL Queen Square Institute of Neurology, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Negin","family":"Holland","sequence":"additional","affiliation":[{"name":"Department of Clinical Neurosciences and MRC (Medical Research Council) Cognition and Brain Sciences Unit, University of Cambridge, Cambridge, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viorica","family":"Chelban","sequence":"additional","affiliation":[{"name":"Department of Clinical and Movement Neurosciences, UCL (University College London) Queen Square Institute of Neurology, London, United Kingdom"},{"name":"Movement Disorders Centre, UCL Queen Square Institute of Neurology, London, United Kingdom"},{"name":"Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. Simon","family":"Jones","sequence":"additional","affiliation":[{"name":"Department of Clinical Neurosciences and MRC (Medical Research Council) Cognition and Brain Sciences Unit, University of Cambridge, Cambridge, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Lamb","sequence":"additional","affiliation":[{"name":"Department of Clinical and Movement Neurosciences, UCL (University College London) Queen Square Institute of Neurology, London, United Kingdom"},{"name":"Movement Disorders Centre, UCL Queen Square Institute of Neurology, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Rawlinson","sequence":"additional","affiliation":[{"name":"Department of Clinical and Movement Neurosciences, UCL (University College London) Queen Square Institute of Neurology, London, United Kingdom"},{"name":"Movement Disorders Centre, UCL Queen Square Institute of Neurology, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Guo","sequence":"additional","affiliation":[{"name":"Department of Clinical and Movement Neurosciences, UCL (University College London) Queen Square Institute of Neurology, London, United Kingdom"},{"name":"Movement Disorders Centre, UCL Queen Square Institute of Neurology, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alyssa A.","family":"Costantini","sequence":"additional","affiliation":[{"name":"Department of Clinical and Movement Neurosciences, UCL (University College London) Queen Square Institute of Neurology, London, United Kingdom"},{"name":"Movement Disorders Centre, UCL Queen Square Institute of Neurology, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela M. X.","family":"Tan","sequence":"additional","affiliation":[{"name":"Department of Clinical and Movement Neurosciences, UCL (University College London) Queen Square Institute of Neurology, London, United Kingdom"},{"name":"Movement Disorders Centre, UCL Queen Square Institute of Neurology, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda J.","family":"Heslegrave","sequence":"additional","affiliation":[{"name":"UK Dementia Research Institute, UCL Queen Square Institute of Neurology, London, United Kingdom"},{"name":"Dementia Research Centre, Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Roncaroli","sequence":"additional","affiliation":[{"name":"Department of Neurology, Manchester Academic Health Science Centre, Salford Royal NHS (National Health Service) Foundation Trust, University of Manchester, Manchester, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes C.","family":"Klein","sequence":"additional","affiliation":[{"name":"Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olaf","family":"Ansorge","sequence":"additional","affiliation":[{"name":"Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kieren S. J.","family":"Allinson","sequence":"additional","affiliation":[{"name":"Department of Clinical Neurosciences and MRC (Medical Research Council) Cognition and Brain Sciences Unit, University of Cambridge, Cambridge, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zane","family":"Jaunmuktane","sequence":"additional","affiliation":[{"name":"Reta Lila Weston Institute, UCL Queen Square Institute of Neurology, London, United Kingdom"},{"name":"Queen Square Brain Bank for Neurological Disorders, UCL Queen Square Institute of Neurology, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janice L.","family":"Holton","sequence":"additional","affiliation":[{"name":"Reta Lila Weston Institute, UCL Queen Square Institute of Neurology, London, United Kingdom"},{"name":"Queen Square Brain Bank for Neurological Disorders, UCL Queen Square Institute of Neurology, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamas","family":"Revesz","sequence":"additional","affiliation":[{"name":"Reta Lila Weston Institute, UCL Queen Square Institute of Neurology, London, United Kingdom"},{"name":"Queen Square Brain Bank for Neurological Disorders, UCL Queen Square Institute of Neurology, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas T.","family":"Warner","sequence":"additional","affiliation":[{"name":"Reta Lila Weston Institute, UCL Queen Square Institute of Neurology, London, United Kingdom"},{"name":"Queen Square Brain Bank for Neurological Disorders, UCL Queen Square Institute of Neurology, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Lees","sequence":"additional","affiliation":[{"name":"Reta Lila Weston Institute, UCL Queen Square Institute of Neurology, London, United Kingdom"},{"name":"Queen Square Brain Bank for Neurological Disorders, UCL Queen Square Institute of Neurology, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Zetterberg","sequence":"additional","affiliation":[{"name":"UK Dementia Research Institute, UCL Queen Square Institute of Neurology, London, United Kingdom"},{"name":"Dementia Research Centre, Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, London, United Kingdom"},{"name":"Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucy L.","family":"Russell","sequence":"additional","affiliation":[{"name":"Dementia Research Centre, Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Bocchetta","sequence":"additional","affiliation":[{"name":"Dementia Research Centre, Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan D.","family":"Rohrer","sequence":"additional","affiliation":[{"name":"Dementia Research Centre, Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nigel M.","family":"Williams","sequence":"additional","affiliation":[{"name":"Institute of Psychological Medicine and Clinical Neurosciences, MRC Centre for Neuropsychiatric Genetics and Genomics, Cardiff University, Cardiff, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald G.","family":"Grosset","sequence":"additional","affiliation":[{"name":"Institute of Neurological Sciences, Queen Elizabeth University Hospital, Glasgow, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Burn","sequence":"additional","affiliation":[{"name":"Faculty of Medical Sciences, Newcastle University, Newcastle, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Pavese","sequence":"additional","affiliation":[{"name":"Faculty of Medical Sciences, Newcastle University, Newcastle, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Gerhard","sequence":"additional","affiliation":[{"name":"Departments of Geriatrics and Nuclear Medicine, Universit\u00e4tsklinikum Essen, Essen, Germany"},{"name":"Division of Neuroscience and Experimental Psychology, University of Manchester, Manchester, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Kobylecki","sequence":"additional","affiliation":[{"name":"Department of Neurology, Manchester Academic Health Science Centre, Salford Royal NHS (National Health Service) Foundation Trust, University of Manchester, Manchester, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. Nigel","family":"Leigh","sequence":"additional","affiliation":[{"name":"Department of Neuroscience, Brighton and Sussex Medical School, Brighton, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alistair","family":"Church","sequence":"additional","affiliation":[{"name":"Department of Neurology, Royal Gwent Hospital, Newport, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele T. M.","family":"Hu","sequence":"additional","affiliation":[{"name":"Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Woodside","sequence":"additional","affiliation":[{"name":"Department of Clinical and Movement Neurosciences, UCL (University College London) Queen Square Institute of Neurology, London, United Kingdom"},{"name":"Movement Disorders Centre, UCL Queen Square Institute of Neurology, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry","family":"Houlden","sequence":"additional","affiliation":[{"name":"Department of Clinical and Movement Neurosciences, UCL (University College London) Queen Square Institute of Neurology, London, United Kingdom"},{"name":"Movement Disorders Centre, UCL Queen Square Institute of Neurology, London, United Kingdom"},{"name":"Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James B.","family":"Rowe","sequence":"additional","affiliation":[{"name":"Department of Clinical Neurosciences and MRC (Medical Research Council) Cognition and Brain Sciences Unit, University of Cambridge, Cambridge, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huw R.","family":"Morris","sequence":"additional","affiliation":[{"name":"Department of Clinical and Movement Neurosciences, UCL (University College London) Queen Square Institute of Neurology, London, United Kingdom"},{"name":"Movement Disorders Centre, UCL Queen Square Institute of Neurology, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"3","key":"noi190101r1","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/s100720100021","article-title":"Comparison of natural histories of progressive supranuclear palsy and multiple system atrophy.","volume":"22","author":"Testa","year":"2001","journal-title":"Neurol Sci"},{"issue":"9192","key":"noi190101r2","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1016\/S0140-6736(99)04137-9","article-title":"Prevalence of progressive supranuclear palsy and multiple system atrophy: a cross-sectional study.","volume":"354","author":"Schrag","year":"1999","journal-title":"Lancet"},{"issue":"pt 7","key":"noi190101r3","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1093\/brain\/124.7.1438","article-title":"The prevalence of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) in the UK.","volume":"124","author":"Nath","year":"2001","journal-title":"Brain"},{"issue":"18","key":"noi190101r4","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1212\/WNL.0000000000002638","article-title":"Prevalence, characteristics, and survival of frontotemporal lobar degeneration syndromes.","volume":"86","author":"Coyle-Gilchrist","year":"2016","journal-title":"Neurology"},{"issue":"pt 4","key":"noi190101r5","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1093\/brain\/awf080","article-title":"The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service.","volume":"125","author":"Hughes","year":"2002","journal-title":"Brain"},{"issue":"7","key":"noi190101r6","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/S1474-4422(14)70088-2","article-title":"Davunetide in patients with progressive supranuclear palsy: a randomised, double-blind, placebo-controlled phase 2\/3 trial.","volume":"13","author":"Boxer","year":"2014","journal-title":"Lancet Neurol"},{"issue":"4","key":"noi190101r7","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1002\/mds.25824","article-title":"A phase 2 trial of the GSK-3 inhibitor tideglusib in progressive supranuclear palsy.","volume":"29","author":"Tolosa","year":"2014","journal-title":"Mov Disord"},{"issue":"3","key":"noi190101r8","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1002\/acn3.290","article-title":"Plasma neurofilament light chain predicts progression in progressive supranuclear palsy.","volume":"3","author":"Rojas","year":"2016","journal-title":"Ann Clin Transl Neurol"},{"key":"noi190101r9","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1001\/archneur.1964.00460160003001","article-title":"Progressive supranuclear palsy: a heterogeneous degeneration involving the brain stem, basal ganglia and cerebellum with vertical gaze and pseudobulbar palsy, nuchal dystonia and dementia.","volume":"10","author":"Steele","year":"1964","journal-title":"Arch Neurol"},{"issue":"1","key":"noi190101r10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1212\/WNL.47.1.1","article-title":"Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop.","volume":"47","author":"Litvan","year":"1996","journal-title":"Neurology"},{"issue":"3","key":"noi190101r11","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/S1474-4422(09)70042-0","article-title":"Progressive supranuclear palsy: clinicopathological concepts and diagnostic challenges.","volume":"8","author":"Williams","year":"2009","journal-title":"Lancet Neurol"},{"issue":"6","key":"noi190101r12","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1002\/mds.26987","article-title":"Clinical diagnosis of progressive supranuclear palsy: the Movement Disorder Society criteria.","volume":"32","author":"H\u00f6glinger","year":"2017","journal-title":"Mov Disord"},{"key":"noi190101r13","article-title":"Neuropathological validation of the MDS-PSP criteria with PSP and other frontotemporal lobar degeneration [published online January 15, 2019].","author":"Gazzina","journal-title":"bioRxiv"},{"issue":"5","key":"noi190101r14","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1212\/WNL.0b013e31827f0fd1","article-title":"Criteria for the diagnosis of corticobasal degeneration.","volume":"80","author":"Armstrong","year":"2013","journal-title":"Neurology"},{"issue":"pt 7","key":"noi190101r15","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1093\/brain\/awq123","article-title":"Does corticobasal degeneration exist? a clinicopathological re-evaluation.","volume":"133","author":"Ling","year":"2010","journal-title":"Brain"},{"issue":"8","key":"noi190101r16","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1136\/jnnp-2013-307035","article-title":"Validation of the new consensus criteria for the diagnosis of corticobasal degeneration.","volume":"85","author":"Alexander","year":"2014","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"9","key":"noi190101r17","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1212\/01.wnl.0000324625.00404.15","article-title":"Second consensus statement on the diagnosis of multiple system atrophy.","volume":"71","author":"Gilman","year":"2008","journal-title":"Neurology"},{"issue":"4","key":"noi190101r18","doi-asserted-by":"publisher","first-page":"947","DOI":"10.3233\/JPD-150662","article-title":"Tracking Parkinson\u2019s: study design and baseline patient data.","volume":"5","author":"Malek","year":"2015","journal-title":"J Parkinsons Dis"},{"issue":"8","key":"noi190101r19","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1212\/WNL.57.8.1497","article-title":"Improved accuracy of clinical diagnosis of Lewy body Parkinson\u2019s disease.","volume":"57","author":"Hughes","year":"2001","journal-title":"Neurology"},{"issue":"8","key":"noi190101r20","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1002\/mds.v34.8","article-title":"How to apply the movement disorder society criteria for diagnosis of progressive supranuclear palsy.","volume":"34","author":"Grimm","year":"2019","journal-title":"Mov Disord"},{"issue":"pt 6","key":"noi190101r21","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1093\/brain\/awm032","article-title":"A clinical rating scale for progressive supranuclear palsy.","volume":"130","author":"Golbe","year":"2007","journal-title":"Brain"},{"issue":"12","key":"noi190101r22","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1002\/(ISSN)1531-8257","article-title":"Development and validation of the Unified Multiple System Atrophy Rating Scale (UMSARS).","volume":"19","author":"Wenning","year":"2004","journal-title":"Mov Disord"},{"issue":"15","key":"noi190101r23","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1002\/mds.v23:15","article-title":"Movement Disorder Society\u2013sponsored revision of the Unified Parkinson\u2019s Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results.","volume":"23","author":"Goetz","year":"2008","journal-title":"Mov Disord"},{"issue":"4","key":"noi190101r25","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1111\/jgs.2005.53.issue-4","article-title":"The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment.","volume":"53","author":"Nasreddine","year":"2005","journal-title":"J Am Geriatr Soc"},{"issue":"11","key":"noi190101r26","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1002\/(ISSN)1099-1166","article-title":"The Addenbrooke\u2019s Cognitive Examination Revised (ACE-R): a brief cognitive test battery for dementia screening.","volume":"21","author":"Mioshi","year":"2006","journal-title":"Int J Geriatr Psychiatry"},{"issue":"1-2","key":"noi190101r27","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3109\/21678421.2013.805784","article-title":"Screening for cognition and behaviour changes in ALS.","volume":"15","author":"Abrahams","year":"2014","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"issue":"8","key":"noi190101r28","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1136\/jnnp.2010.221853","article-title":"CSF Alzheimer\u2019s disease-like pattern in corticobasal syndrome: evidence for a distinct disorder.","volume":"82","author":"Borroni","year":"2011","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"noi190101r29","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1002\/ana.25308","article-title":"Variation at the TRIM11 locus modifies progressive supranuclear palsy phenotype.","volume":"84","author":"Jabbari","year":"2018","journal-title":"Ann Neurol"},{"issue":"6","key":"noi190101r30","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/S1474-4422(19)30139-5","article-title":"Safety of the tau-directed monoclonal antibody BIIB092 in progressive supranuclear palsy: a randomised, placebo-controlled, multiple ascending dose phase 1b trial.","volume":"18","author":"Boxer","year":"2019","journal-title":"Lancet Neurol"},{"issue":"19","key":"noi190101r31","doi-asserted-by":"publisher","first-page":"2016","DOI":"10.1212\/WNL.0000000000003305","article-title":"Progression of brain atrophy in PSP and CBS over 6 months and 1 year.","volume":"87","author":"Dutt","year":"2016","journal-title":"Neurology"},{"issue":"14","key":"noi190101r32","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.1002\/mds.v29.14","article-title":"The phenotypic spectrum of progressive supranuclear palsy: a retrospective multicenter study of 100 definite cases.","volume":"29","author":"Respondek","year":"2014","journal-title":"Mov Disord"},{"issue":"10","key":"noi190101r33","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1212\/WNL.0000000000003680","article-title":"Blood-based NfL: a biomarker for differential diagnosis of parkinsonian disorder.","volume":"88","author":"Hansson","year":"2017","journal-title":"Neurology"},{"issue":"11","key":"noi190101r34","doi-asserted-by":"publisher","first-page":"2602","DOI":"10.1007\/s00415-018-9038-x","article-title":"Comparative cognitive and neuropsychiatric profiles between Parkinson\u2019s disease, multiple system atrophy and progressive supranuclear palsy.","volume":"265","author":"Santangelo","year":"2018","journal-title":"J Neurol"},{"issue":"4","key":"noi190101r35","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1097\/WCO.0b013e32833be924","article-title":"Neuropathology of variants of progressive supranuclear palsy.","volume":"23","author":"Dickson","year":"2010","journal-title":"Curr Opin Neurol"},{"key":"noi190101r24","author":"Schwab","year":"1969"}],"container-title":["JAMA Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaneurology\/articlepdf\/2757604\/jamaneurology_jabbari_2019_oi_190101.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,9]],"date-time":"2020-03-09T15:00:45Z","timestamp":1583766045000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaneurology\/fullarticle\/2757604"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,1]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,3,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaneurol.2019.4347","relation":{},"ISSN":["2168-6149"],"issn-type":[{"value":"2168-6149","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3,1]]}}}